Literature DB >> 1775237

Neuroendocrine and behavioural responses to hyperosmolality in rats with lesions of the lateral hypothalamus made by N-methyl-D-aspartate.

J M Clark1, A J Clark, D Warne, E L Rugg, S L Lightman, P Winn.   

Abstract

Excitotoxic lesions of rat lateral hypothalamus produce impairments in eating and drinking, but not motor deficits. However, it has not been established what causes these eating and drinking impairments. In the present experiments, drinking, plasma osmolality and arginine-vasopressin concentration were measured in lateral hypothalamic-lesioned and control rats following systemic injection of hypertonic saline. In response to hyperosmolality, N-methyl-D-aspartate-lesioned rats drank significantly less than controls but showed normal increases in plasma osmolality and arginine-vasopressin concentration. This dissociation of neuroendocrine and behavioural responses suggests that the impairment of rats with excitotoxic lesions of the lateral hypothalamus is unrelated to physiological (as opposed to behavioural) mechanisms of homeostasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775237     DOI: 10.1016/0306-4522(91)90275-s

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  The physiological control of eating: signals, neurons, and networks.

Authors:  Alan G Watts; Scott E Kanoski; Graciela Sanchez-Watts; Wolfgang Langhans
Journal:  Physiol Rev       Date:  2021-09-06       Impact factor: 37.312

2.  The role of hypothalamic ingestive behavior controllers in generating dehydration anorexia: a Fos mapping study.

Authors:  Dawna Salter-Venzon; Alan G Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

3.  N-methyl-D-aspartate lesions of the lateral hypothalamus do not reduce amphetamine or fenfluramine anorexia but enhance the acquisition of eating in response to tail pinch in the rat.

Authors:  J M Clark; A J Clark; P Winn
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.